Superiority of <scp>Low‐Dose</scp> Benzbromarone to <scp>Low‐Dose</scp> Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion - Concepedia

Concepedia

Publication | Open Access

Superiority of <scp>Low‐Dose</scp> Benzbromarone to <scp>Low‐Dose</scp> Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion

DOI Full Paper Access

54

Citations

22

References

2022

Year

Fei Yan, Xiaomei Xue, Jie Lü, Nicola Dalbeth, Han Qi, Qing Yu, Can Wang, Mingshu Sun, Lingling Cui, Zhen Liu,

Arthritis & Rheumatology

Abstract

Compared to LDFeb, LDBen has superior urate-lowering efficacy and similar safety in treating relatively young and healthy patients with renal uric acid underexcretion-type gout.

References

	Year	Citations

Page 1